10
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Proteolytic Capacity in Human Plasma Part I Measurement of proteolytic activity in the presence of natural inhibitors and study of the inter-individual variations

Pages 216-226 | Received 06 Nov 1967, Accepted 04 Mar 1968, Published online: 08 Jul 2009

References

  • Bennett N. B. A method for the quantitative assay of inhibitor of plasminogen activation in human serum. Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 17: 12
  • Berg W., Korsan-Bengtsen K., Ygge J. Preparation of human plasminogen suitable as substrate for quantitative determination of plasminogen activators. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 15: 511
  • Blix S. The proactivator of the fibrinolytic system in human plasma. Acta med. scand. 1962; 171: 83
  • Blix S. The quantitative determination of fibrinolytic inhibitors in plasma or serum by means of the fibrin plate. Scand. J. clin. Lab. Invest. 1964; 16: 403
  • Borchgrevink C. F., Waaler B. A. The secondary bleeding time. Acta med. scand. 1958; 162: 361
  • Davis B. J. Disc electrophoresis II. Method and application to human serum proteins. Ann. N.Y. Acad. Sci. 1964; 121: 404
  • Eeberg O. Studies on Human Blood Coagulation and Hemostasis. Thesis, Universitetsforlaget, Oslo 1964
  • Fagerhol M. K., Laurell C.-B. The polymorphism of “prealbumins” and α, -antitrypsin in human sera. Clin. chim. Acta. 1967; 16: 199
  • Godal H. C. A simple syneresis procedure for the assay of fibrinogen. Scand. J. clin. Lab. Invest. 1961; 13: 530
  • Godal H. C., Helle I. In vitro studies on fibrinogenolysis induced by streptokinase. Scand. J. clin. Lab. Invest. 1963; 15: 303
  • Jacobsen C. D. The caseinolytic method for determination of plasminogen-plasmin in human plasma and serum. Scand. J. clin. Lab. Invest. 1964; 16: 372
  • Jacobsen C. D. The antiplasmin activity of human plasma and serum and its dependence on ions. Scand. J. clin. Lab. Invest. 1964; 16: 383
  • Jacobsen C. D., Chandler A. B. Thrombolysis in vitro I. Method, comparison of various throm-bolytic agents, and factors influencing thrombolysis. Scand. J. clin. Lab. Invest. 1965; 17: 209
  • Jacobsen C. D., Chandler A. B. Thrombolysis in vitro II. Thrombolytic effect of streptokinase and urokinase in health and disease. Scand. J. clin. Lab. Invest. 1965; 17: 225
  • Jacobsen C. D. A family with low proteolytic capacity in plasma, probably related to a low plasminogen content. Scand. J. clin. Lab. Invest. 1966; 18: 359
  • Jacobsen C. D. The use of N-ethyl-urethan in plasma plasminogen assay. Scand. J. clin. Lab. Invest. 1968; 21: 182–186
  • Jacobsen C. D., Unpublished observations
  • Laursen B., Gormsen J. Spontaneous fibrinolysis demonstrated by immunological technique. Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 17: 42
  • Norman P. S. Antiplasmins. Fed. Proc. 1966; 25: 63
  • Ornstein L. Disc electrophoresis -I Background and theory. Ann. N.Y. Acad. Sci. 1964; 121: 321
  • Owren P. A. The coagulation of blood. Investigation on a new clotting factor. Thesis. Acta med. scand. 1947; 194, Suppl.
  • Paraskevas Maria Nilsson, Marie Inga, Martinsson Gunilla. A method for determining serum inhibitors of plasminogen activation. Scand. J. clin. Lab. Invest. 1962; 14: 138
  • Scheidegger J. J. Une micro-méthode de l'immune-électrophorèse. Int. Arch. Allergy 1955; 7: 103

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.